Shai Agassi
Angel Investor
Tel Aviv, Israel
Shai Agassi is a successful Israeli entrepreneur with proven track record who sold three of his startups for the aggregate sum of more than $500M+ in total. Agassi is most recognized for his role as founder of Better Place - a globally renowned leader in the EV space. He is the original inventor of the modern incarnation of the automated batteryswitch concept and the business model of treating the EV battery as consumable, rather than as an attached component.Prior to that, Agassi served as the President of SAP's Product and Technology where he managed 12,000 engineers in 50 countries around the world. Agassi was the youngest member of SAP's management board and is credited with a number of its key products and technology products. Agassi holds tens of patents to his name in a multitude of fields, and received numerous awards and accolades, amongst them: Time 100 Most Influential People in the World (2009), CNN/Time 20 Most Influential People Global Economy (2003), Scientific American Top 20 Innovators (2009), Fast Company 3rd Most.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Shai Agassi invests in
Stages Shai Agassi invests in
Countries Shai Agassi invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications. | $12M / Series C / Jan 31, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shai Agassi invest in?
Shai Agassi invests primarily in Medical, Health Care and Medical Device startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Shai Agassi?
Public channels for Shai Agassi include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Shai Agassi last invest?
The most recent investment recorded for Shai Agassi closed in Jan 2019. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
